From Brain to Behaviour: A Review of Neuropsychiatric Treatments for Mood and Anxiety Disorders
1*Muskan Tomar, 2Harshit Shringi and 3Manoj Goyal
1,3Department of Pharmacology Indore Mahavidyalaya, Indore - 453111 (India) 2Parijat College of Pharmacy, Indore - 452010 (India) Corresponding Author – Muskan Tomar Department of Pharmacology *Email – muskantomar808@gmail.com
ABSTRACT
Among the most common neuropsychiatric conditions, depression and anxiety impact millions of people worldwide and present serious public health issues. These disorders cause significant emotional, cognitive, and functional impairments due to intricate interplay between neurobiological, psychosocial, and environmental variables. With an emphasis on their neuropsychological foundations, this study offers a thorough examination of both established and novel therapy approaches for treating anxiety and depression. For many individuals, traditional pharmaceutical treatments including benzodiazepines, serotonin-norepinephrine reuptake inhibitors (SNRIs), and selective serotonin reuptake inhibitors (SSRIs) continue to be the first choice. Nevertheless, these treatments frequently have drawbacks because of their partial response, delayed commencement of action, and adverse effects.